Basic Information
Glycostem Therapeutics Focuses on the Development of Stem Cell-Derived Natural Killer Cells (NK Cells). NK cells are rising stars in the field of cellular immunotherapy due to their precisely regulated "natural killing" of cancer cells, playing a crucial role in controlling and even curing solid and hematologic malignancies such as Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM).
Glycostem Therapeutics B.V.
Netherlands
15~50 people
January 01, 2007
Office@Glycostem.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios